Neurocysticercosis: Report of three cases and recommendations of treatment;Neurocisticercosis: Recomendaciones de tratamiento a propósito de tres casos

Anales de Medicina Interna

Volumn 21, Issue 8, 2004, Pages 382-386

  Álvarez Rodríguez, Esther ^a,b   Torres Garate R ^a   Gutierrez Larrainzar A ^a   Cabello, J ^a   Espinos Perez D ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b NONE   (Spain)

Author keywords

Albendazole; Antiparasitic drugs; Cestode; Cysticercosis; Epilepsy; Neurocysticercosis; Praziquantel; Taenia solium

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; PRAZIQUANTEL; STEROID;

ADULT; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CYST; ENCEPHALITIS; EPILEPSY; FEMALE; HUMAN; HYDROCEPHALUS; IMMIGRANT; INTRACRANIAL HYPERTENSION; MALE; NEUROCYSTICERCOSIS; NEUROIMAGING; PARASITE LOCALIZATION; SEIZURE; TAENIA SOLIUM; TREATMENT INDICATION;

ADULT; ANTHELMINTICS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROCYSTICERCOSIS; PRACTICE GUIDELINES; PRAZIQUANTEL; TAENIA SOLIUM; TREATMENT OUTCOME;

EID: 5644250738     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Del Brutto OH. Cerebrovascular disease in the tropics. Rev Neurol 2001; 33: 750-762.
2. Martinez HR, Rangel-Guerra R, Arredondo-Estrada JM, Marfil A, Onofre J. Medical and surgical treatment in neurocysticercosis: a magnetic resonance study of 161 cases. J Neurol Sci 1995; 130: 25-34.
3. García HH, Evans CAW, Nash TE et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002; 15: 747-756.
4. Coyle CM, Winner M, Tanowitz HB. Cysticercosis. En: Guerrant RL, Walker DM, Weller PF, eds. Essentials of tropical infectious diseases. Philadelphia: Churchill Livingstone, 2001; 472-476.
5. Chang KH, Han MH. MRI of CNS parasitic disease. J Magn Reson Imaging 1998; 8: 297-307.
6. García HH, Parkhouse RM, Gillman RH et al. Serum antigen detection in the diagnosis, treatment, and follow-up of neucysticercosis patients. Trans R Soc Trop Med Hyg 2000; 94: 673-676.
7. Del Brutto OH, Sotelo J. Neurocysticercosis: an update. Rev Infect Dis 1998; 10: 1075-1087.
8. García HH, González AE, Evans CA, Gilman RH. Cisticercosis working group in Peru. Lancet 2003; 362: 547-556.
9. Carpid A. Neurocysticercosis: an update. Lancet Infect Dis 2002; 2(12): 751-762.
10. Del Brutto OH, Rajshekhar V, White AC et al. Proponed diagnostic criteria for neurocysticercosis. Neurology 2001; 57(2): 177-183.
11. Pérez-López C, Isla-Guerrero A, Álvarez F et al. Update in neurocysticercosis treatment. Rev Neurol 2003; 36(9): 805-811.
12. Font C, Ruiz JA, Muñoz C, Pardós F, Corachan M. Neurocisticercosis en España. A propósito de 4 casos observados en pacientes inmigrantes de países endémicos. An Med Interna (Madrid) 1999; 16: 89-91.